Rexahn Pharmaceuticals to receive drug delivery patent; New radiation system cleared in Japan;

> Rexahn Pharmaceuticals announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office. The patent will cover Rexahn's Polymeric Systems for the Delivery of Anticancer Drugs. Release

> Japan's Ministry of Health issued a clearance for the Elekta Versa HD advanced radiation treatment system. Elekta touts the product's tumor-targeting technologies. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.